171 related articles for article (PubMed ID: 19779967)
41.
Santos-Cuevas C; Davanzo J; Ferro-Flores G; García-Pérez FO; Ocampo-García B; Ignacio-Alvarez E; Gómez-Argumosa E; Pedraza-López M
Nucl Med Biol; 2017 Sep; 52():1-6. PubMed ID: 28575794
[TBL] [Abstract][Full Text] [Related]
42. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
43. Imaging of therapy-induced apoptosis using (99m)Tc-HYNIC-annexin V in thymoma tumor-bearing mice.
Wong E; Kumar V; Howman-Giles RB; Vanderheyden JL
Cancer Biother Radiopharm; 2008 Dec; 23(6):715-26. PubMed ID: 19111046
[TBL] [Abstract][Full Text] [Related]
44. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
45. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
[TBL] [Abstract][Full Text] [Related]
46. Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Liu C; Zhu Y; Su H; Xu X; Zhang Y; Ye D; Hu S
Prostate; 2018 Dec; 78(16):1215-1221. PubMed ID: 30027591
[TBL] [Abstract][Full Text] [Related]
47. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response.
Kartachova M; Haas RL; Olmos RA; Hoebers FJ; van Zandwijk N; Verheij M
Radiother Oncol; 2004 Sep; 72(3):333-9. PubMed ID: 15450733
[TBL] [Abstract][Full Text] [Related]
48. Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography.
Gabrielson KL; Mok GS; Nimmagadda S; Bedja D; Pin S; Tsao A; Wang Y; Sooryakumar D; Yu SJ; Pomper MG; Tsui BM
Mol Imaging; 2008; 7(3):132-8. PubMed ID: 19123983
[TBL] [Abstract][Full Text] [Related]
49. Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients.
Rottey S; Van den Bossche B; Slegers G; Van Belle S; van de Wiele C
Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):127-32. PubMed ID: 19039304
[TBL] [Abstract][Full Text] [Related]
50. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Kopecky M; Semecky V; Trejtnar F; Laznicek M; Laznickova A; Nachtigal P; Decristoforo C; Mather SJ; Mäcke HR
Nucl Med Biol; 2004 Feb; 31(2):231-9. PubMed ID: 15013489
[TBL] [Abstract][Full Text] [Related]
51. Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.
Vermeersch H; Mervillie K; Lahorte C; Loose D; Dierck RA; Steinmetz N; Cuvelier C; Slegers G; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):1016-21. PubMed ID: 15014904
[TBL] [Abstract][Full Text] [Related]
52. [Feasibility of apoptosis-imaging agent 99mTc-HYNIC-annexin V in early assessment of chemotherapeutic effect on tumor models].
Lan XL; Zhang YX; He Y; Sun X; An R; Gao ZR; Cao GX
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):737-40. PubMed ID: 19173800
[TBL] [Abstract][Full Text] [Related]
53. A Comparison of [
Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H
Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938
[TBL] [Abstract][Full Text] [Related]
54. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of 99mTc-HYNIC annexin-V imaging in squamous cell carcinoma of the head and neck.
Loose D; Vermeersch H; De Vos F; Deron P; Slegers G; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):47-52. PubMed ID: 17906858
[TBL] [Abstract][Full Text] [Related]
56. The synthesis, magnetic purification and evaluation of 99mTc-labeled microbubbles.
Lazarova N; Causey PW; Lemon JA; Czorny SK; Forbes JR; Zlitni A; Genady A; Foster FS; Valliant JF
Nucl Med Biol; 2011 Nov; 38(8):1111-8. PubMed ID: 21741260
[TBL] [Abstract][Full Text] [Related]
57. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
[TBL] [Abstract][Full Text] [Related]
58. Radiolabeling of annexin A5 with (99m)Tc: comparison of HYNIC-Tc vs. iminothiolane-Tc-tricarbonyl conjugates.
Biechlin ML; Bonmartin A; Gilly FN; Fraysse M; du Moulinet d'Hardemare A
Nucl Med Biol; 2008 Aug; 35(6):679-87. PubMed ID: 18678353
[TBL] [Abstract][Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
